Israeli Team Developing Coronavirus Vaccine Raises $12M For New Startup, To Begin Summer Trials
The new company, MigVax, is an affiliate of The Migal Galilee Research Institute and will pioneer the effort to develop the vaccine.
April 22, 2020
Sponsored by the Asper Foundation and Reichman University
